Alkermes plc (ALKS) - מזומן למניה

סמל תאגידי ולוגו של Alkermes plc (ALKS)

Alkermes plc (ALKS) is protected by patents on complex injectable formulations, which limits generic expansion. A sufficient liquidity surplus allows the company to fund R&D without external borrowing. The cash per share metric visualizes this margin of safety, and its current level is 4.54. The chronic nature of psychiatric disorders guarantees the company a stable revenue stream from patients' continuous medication use.

Alkermes Inc. (ALKS) - יתרות מזומנים למניה מ-04.07.2022 עד 20.11.2026

פילוחים אנליטיים של חברת Alkermes plc

- מחיר ותחזית קונצנזוס למחירים:
- פרטי פוזיציית מזומנים ותזרימי מזומנים:
ניתוח כללי של החברה:Alkermes Corp - ALKS
מוצר מקורי של Alkermes

This metric reflects the amount of free cash flow per common share, allowing for an assessment of the company's actual liquidity and internal reserves. For the biopharmaceutical business of Alkermes plc (ALKS), with its patent portfolio and royalties, an analysis of the issuer's cash per share via the GURU.Markets platform reveals a balance between R&D investments and operational efficiency, determining the fundamental stability of the business.